Source:http://linkedlifedata.com/resource/pubmed/id/12526974
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-1-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0002-9270
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
98
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
223-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12526974-Drug Combinations,
pubmed-meshheading:12526974-Giant Cells,
pubmed-meshheading:12526974-Hepatitis,
pubmed-meshheading:12526974-Humans,
pubmed-meshheading:12526974-Interferon-alpha,
pubmed-meshheading:12526974-Male,
pubmed-meshheading:12526974-Middle Aged,
pubmed-meshheading:12526974-Remission Induction,
pubmed-meshheading:12526974-Ribavirin
|
pubmed:year |
2003
|
pubmed:articleTitle |
Successful treatment of giant cell hepatitis with Rebetron (interferon/ribavirin).
|
pubmed:publicationType |
Letter,
Case Reports
|